Thank You for Downloading
Your download is complete—head to your Downloads folder to explore the insights.
Doug Drysdale is the Chief Executive Officer of Cybin. During Doug’s tenure as CEO of Cybin, the company was taken public on the NYSE and now has two clinical-stage programs in development for the treatment of major depressive disorder and generalized anxiety disorder. During Doug’s 35+ years of experience in the healthcare sector, he has built cohesive management teams, recruited board members, created multinational operations, and has raised around $4 billion of both public and private capital. As founding CEO of Alvogen, Doug led the company from inception to around $500mm in revenues, across 35 countries. Previously, Doug was Head of M&A at Actavis Group, leading 15 corporate acquisitions across three continents, between 2004 and 2008. In 2012 Doug was named E&Y Entrepreneur of the Year.